TrialInternational journal of hematology2025

A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.

Hiroki Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.